Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-02-13
Mulholland Kristen Files Johnson & Johnson (JNJ) Form 4 - February 13, 2026
Mulholland Kristen traded 6.6K JNJ shares worth $387.1K in this Form 4 filing, reported to the SEC on 2026-02-13.
- Insider
- Mulholland Kristen
- Issuer
- Johnson & Johnson JNJ · NYSE
- Filed
- Period
- 2026-02-13
- Accession
- 0000200406-26-000042
- Source
- Official filing on sec.gov ↗
Transactions (8)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Mulholland Kristen | 2026-02-15 | Sell | 251 | $243.45 | $61.1K | Direct |
| Mulholland Kristen | 2026-02-15 | Buy | 419 | $0.00 | $0.00 | Direct |
| Mulholland Kristen | 2026-02-15 | Sell | 172 | $243.45 | $41.9K | Direct |
| Mulholland Kristen | 2026-02-15 | Buy | 575 | $0.00 | $0.00 | Direct |
| Mulholland Kristen | 2026-02-13 | Buy | 410 | $0.00 | $0.00 | Direct |
| Mulholland Kristen | 2026-02-13 | Sell | 135 | $244.55 | $33.0K | Direct |
| Mulholland Kristen | 2026-02-13 | Buy | 3.6K | $0.00 | $0.00 | Direct |
| Mulholland Kristen | 2026-02-13 | Sell | 1.0K | $244.55 | $251.2K | Direct |
| Net change | +3.4K | −$387.1K | ||||
About Johnson & Johnson
Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.
Track JNJ insider activity
Get alerted when Johnson & Johnson executives buy or sell their shares.